Back
4D Molecular Therapeutics Stock Predictions
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
26
FDMT
4D Molecular Therapeutics
Last Price:
7.91
Seasonality Move:
57.95%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here4D Molecular Therapeutics Stock Forecast
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 29.5% based on the past 3 years of stock performance.
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $7.70. The Score for FDMT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal. - FDMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 29.5% based on the past 3 years of stock performance.
4D Molecular Therapeutics Stock Rating
Sell
26
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics overpriced?
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
36.25
52-Week Low:
7.72
Prediction Charts
Market Cap:
400.17M
Price in USD:
7.70
Volume:
534.27K
Beta:
2.86
Technical Analysis
SMA50:
10.72
SMA100:
14.40
SMA200:
20.55
52-Wk Change:
-26.88%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company. -
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 7.70 USD today. -
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 8.27 | 8.15 | 8.45 | 8.09 |
| Oct-28 | 8.20 | 8.57 | 8.68 | 8.20 |
| Oct-29 | 8.47 | 8.20 | 8.62 | 8.13 |
| Oct-30 | 8.20 | 8.27 | 8.42 | 8.05 |
| Oct-31 | 8.22 | 8.01 | 8.30 | 7.99 |
| Nov-1 | 8.05 | 8.10 | 8.26 | 8.01 |
| Nov-4 | 8.05 | 8.18 | 8.43 | 7.98 |
| Nov-5 | 8.18 | 8.39 | 8.44 | 8.03 |
| Nov-6 | 8.66 | 8.35 | 8.74 | 8.30 |
| Nov-7 | 8.40 | 8.28 | 8.62 | 8.22 |
| Nov-8 | 8.31 | 8.12 | 8.47 | 8.07 |
| Nov-11 | 8.21 | 8.08 | 8.34 | 8.00 |
| Nov-12 | 7.98 | 7.87 | 8.12 | 7.72 |
| Nov-13 | 7.98 | 7.70 | 8.02 | 7.68 |
4D Molecular Therapeutics Earnings
4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
4D Molecular Therapeutics Forecast Revenue Growth
4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.49 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.